MyoKardia is a clinical stage biopharmaceutical company that develops therapies for the treatment of serious and neglected rare cardiovascular diseases. Its lead product candidate is MYK-461, a small...
Myriad RBM is the world's leading multiplexed immunoassay testing laboratory, providing comprehensive protein biomarker services based on its Multi-Analyte Profiling (MAP) technology platform. This...
NanoBio Corporation, a biopharmaceutical company, focuses on developing and commercializing vaccines and anti-infective treatments. The company’s NanoStat vaccine technology employs a novel oil-in-water...
Nanobiotix is a nanomedicine company dedicated to the development of new treatments for cancer based on the combined application of nanotechnologies and biotechnologies. Nanobiotix has developed a new...
Nanospectra Biosciences, Inc. develops and commercializes particle-based therapy devices for the selective and precise thermal destruction of solid tumors. The company’s portfolio includes AuroLase...
NanoString Technologies provides life science tools for translational research and molecular diagnostics. The company's technology enables a wide variety of basic research, translational medicine and...
Nanotherapeutics manufactures and develops biopharmaceutical products. The company develops biodefense medical countermeasures, CNS, wound healing, addiction and pain, oncology, anti-infective, vaccines,...
NantHealth inc. combines science and technology through an integrated clinical platform to provide health information at the point of care for critical illnesses. The company was founded in 2010 and...
